EBV CTLs expressing CD30 chimeric receptor

EBV-specific cytotoxic T lymphocytes with CD30 CAR · Baylor College of Medicine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EBV CTLs expressing CD30 chimeric receptor, covering 2026-02-06 to 2026-02-06. Get the full timeline:

Most recent: Clinical Trial Update: EBV CTLs Expressing CD30 Chimeric Receptors For CD 30+ Lymphoma [Phase 1]